ArticleCureus2025
Perioperative Considerations in a Patient With Oculopharyngeal Muscular Dystrophy: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Oculopharyngeal muscular dystrophy (OPMD) is a rare, late-onset neuromuscular disorder that is classically characterized by dysphagia, ptosis, and proximal limb weakness. Although OPMD is typically mild in progression, it presents unique challenges in the perioperative setting due to pharyngeal muscle weakness, increased risk of aspiration, and sensitivity to neuromuscular blocking agents. Here, we discuss the anesthetic management of a 75-year-old male with OPMD undergoing an elective reverse total shoulder arthroplasty. Though preoperative pulmonary function testing showed preserved respiratory mechanics, the patient had previously reported dysphagia, voice changes, and fatigue. Due to the increased risk for perioperative complications, an anesthetic plan was developed with the primary goals of reducing aspiration risk, minimizing neuromuscular blockade, and facilitating a smooth emergence. For induction of anesthesia, total intravenous agents were used. Inhaled anesthetics were avoided to decrease the risk of residual respiratory depression. Endotracheal intubation was performed under video laryngoscopy after administering a reduced dose of rocuronium. Intraoperatively, train-of-four stimulation was utilized for close monitoring of neuromuscular blockade. Following partial recovery of consciousness after case completion, rocuronium was reversed with sugammadex. The patient was then extubated and monitored in the post-anesthesia care unit. No respiratory sequelae were noted. This case highlights the need for individualized anesthetic planning in patients with OPMD, especially in the context of airway protection and neuromuscular management. Avoiding succinylcholine, limiting non-depolarizing agents, and utilizing neuromuscular monitoring may help mitigate the risk of prolonged paralysis and respiratory compromise. As more aging patients with neuromuscular disorders present for surgery, it is essential to promote increased awareness of the specific anesthetic implications of OPMD. This case contributes to the limited body of literature guiding safe perioperative care in this patient population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.